A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...
Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback